NDC product
Hydrocortisone Acetate
NDC 70752-169 · QUAGEN PHARMACEUTICALS LLC
Key facts
| Product NDC | 70752-169 |
|---|---|
| Proprietary name | Hydrocortisone Acetate |
| Nonproprietary name | Hydrocortisone Acetate |
| Substances | HYDROCORTISONE ACETATE |
| Dosage form | SUPPOSITORY |
| Route | RECTAL |
| Labeler | QUAGEN PHARMACEUTICALS LLC |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Pharmacologic classes | Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC] |
| Marketing start | Jul 18, 2022 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: